ARVN Q1 2020 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$856M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+55.4% YoY

Gross Profit

$6M100.0% margin

Operating Income

-$23M-375.2% margin

Net Income

-$22M-348.4% margin

EPS (Diluted)

$-0.56

QoQ Revenue Growth

+27.5%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$282M

Total Liabilities

$71M

Stockholders' Equity

$212M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+55.4%
Gross Profit	$6M	$4M	+55.4%
Operating Income	-$23M	-$16M	-48.0%
Net Income	-$22M	-$14M	-50.9%